PT  - JOURNAL ARTICLE
AU  - W Yakes
TI  - E-028 Management of Tongue Venous and Lymphatic Malformations
AID  - 10.1136/neurintsurg-2016-012589.100
DP  - 2016 Jul 01
TA  - Journal of NeuroInterventional Surgery
PG  - A59--A59
VI  - 8
IP  - Suppl 1
4099  - http://jnis.bmj.com/content/8/Suppl_1/A59.1.short
4100  - http://jnis.bmj.com/content/8/Suppl_1/A59.1.full
SO  - J NeuroIntervent Surg2016 Jul 01; 8
AB  - Purpose To determine the efficacy of ethanol embolization in management of tongue venous and lymphatic malformations.Materials and methods Thirty-nine patients (22 females, 17 males; mean age: 38 years) presented with tongue low-flow malformations. Forty-seven patients had undergone 61 failed previous procedures (embo, laser, surgery, steroid injection, alpha-interpheron, radiation). All patients had baseline arteriograms and MRs. All patients underwent direct puncture ethanol endovascular therapy.Results Of 39 patients with venous and lymphatic malformations, 32 patients had dramatic reduction and 7 patients’ therapy is on-going with concurrent reductions (mean f/up: 60 months). One patient with AVM required additional surgery and 1 patient with mixed veno-lymphatic malformation required surgical debulking of excess tissues. Minor complications such as tongue blisters (9 instances) healed spontaneously; 3 tongue focal necrosis injuries healed spontaneously; 3 infections responded to antibiotic treatment; 1 focal tongue hemi numbness resolved.Conclusion Ethanol embolotherapy is a primary and consistent form of therapy to eradicate low-flow vascular malformations of the tongue permanently at long-term follow-up. Rarely is concurrent surgery required. Ethanol sclerotherapy is a curative treatment in which recurrences do not occur and permanent ablations are the rule. Complications that occur are minor and rare.Disclosures W. Yakes: None.